Cyclopentolate Hydrochloride Ophthalmic Solution: A Comprehensive Review for Pharmacists

1. Overview and Chemical Profile Cyclopentolate hydrochloride ophthalmic solution (CPH) is a topical mydriatic and cycloplegic agent widely used in ophthalmology to induce pupil dilation (mydriasis) and paralysis of the…

Continue ReadingCyclopentolate Hydrochloride Ophthalmic Solution: A Comprehensive Review for Pharmacists

ZERBAXA

What is ZERBAXA? ZERBAXA is a prescription antibiotic medication composed of two active ingredients: Ceftolozane: A next-generation cephalosporin antibiotic effective against a broad spectrum of Gram-negative bacteria, including multidrug-resistant strains…

Continue ReadingZERBAXA

CRESEMBA

CRESEMBA (Isavuconazonium sulfate) is a prescription medication used to treat specific forms of fungal infections in the blood or body known as \"aspergillosis\" and \"mucormycosis\" in adults 18 years of…

Continue ReadingCRESEMBA

Harlequin Ichthyosis: A Comprehensive Review for Medical Practitioners – Updated Evidence-Based Perspective

Introduction Harlequin ichthyosis (HI) is an exceptionally rare, autosomal recessive, genodermatosis characterized by profound abnormalities in epidermal barrier formation, leading to life-threatening complications in the neonatal period. It is the…

Continue ReadingHarlequin Ichthyosis: A Comprehensive Review for Medical Practitioners – Updated Evidence-Based Perspective

Toxic Epidermal Necrolysis (TEN): A Clinically Focused Review with Contemporary Evidence-Based Management Guidance

Definition & EpidemiologyToxic epidermal necrolysis (TEN) is a rare, life-threatening immune-mediated adverse drug reaction characterized by widespread apoptosis of keratinocytes leading to acute skin and mucosal detachment, resembling severe burn…

Continue ReadingToxic Epidermal Necrolysis (TEN): A Clinically Focused Review with Contemporary Evidence-Based Management Guidance

Revised Clinical Overview of CLOVES Syndrome: Pathogenesis, Diagnosis, Management, and Prognosis – With Reference to Current Guidelines and Evidence

1. Definition and Classification CLOVES syndrome (Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, Skeletal/Spinal Anomalies) is a rare, complex mosaic overgrowth disorder belonging to the broader category of PIK3CA-Related Overgrowth…

Continue ReadingRevised Clinical Overview of CLOVES Syndrome: Pathogenesis, Diagnosis, Management, and Prognosis – With Reference to Current Guidelines and Evidence

Blue Man Syndrome: A Comprehensive Clinical Review of Argyria – Pathophysiology, Diagnosis, Management, and Evidence-Based Insights

Authored for Clinicians | Updated per 2023–2024 Guidelines & Literature Definition and Epidemiology Argyria (Greek argyros, “silver”) is a rare, irreversible dermal deposition disorder caused by chronic exposure to elemental…

Continue ReadingBlue Man Syndrome: A Comprehensive Clinical Review of Argyria – Pathophysiology, Diagnosis, Management, and Evidence-Based Insights

Comprehensive Clinical Overview of Furunculosis: Pathogenesis, Diagnosis, Management, and Prevention Based on Current Evidence and Guidelines

Definition and Epidemiology Furunculosis refers to recurrent or multiple furuncles—deep, painful, inflamed nodules resulting from suppurative infection of the hair follicle and adjacent dermal/subcutaneous tissue. When multiple adjacent follicles coalesce,…

Continue ReadingComprehensive Clinical Overview of Furunculosis: Pathogenesis, Diagnosis, Management, and Prevention Based on Current Evidence and Guidelines

Acute and Chronic Interstitial Nephritis: A ClinicallyFocused Update for Practicing Physicians

Based on current KDIGO guidelines (2024 updates), ASNC position statements, and recent peer-reviewed evidence (UpToDate 2024, NEJM 2023;389:1517–1528; Nat Rev Nephrol 2022;18:653–668) I. Acute Interstitial Nephritis (AIN) Definition & PathophysiologyAcute…

Continue ReadingAcute and Chronic Interstitial Nephritis: A ClinicallyFocused Update for Practicing Physicians